Today's biggest pre-market stock movers: 10 top gainers and losers on Tuesday
Today's biggest pre-market stock movers: 10 top gainers and losers on Tuesday
Welcome back, investors, and I hope you all enjoyed the July 4th weekend! We're getting right back into the swing of things today with a look at the biggest pre-market stock movers for Tuesday!
欢迎回来，投资者们，我希望你们都喜欢7月4日的周末！今天我们马上回到正题，来看看周二最大的盘前股票走势吧！。
Let's jump right into those pre-market stock movers below!
让我们直接跳到下面那些开盘前的股票行情中去吧！
Pre-Market Stock Movers: 10 Top Gainers
盘前股票交易商：10大涨幅最大的股票
$Advaxis Inc(ADXS.US)$ stock is rocketing more than 65% this morning after announcing a merger deal with Biosight.
$Bridgeline Digital Inc(BLIN.US)$ shares are soaring over 38% after revealing it gained more than $2.5 million in cash last week from warrant exercises.
$BSQUARE Corp(BSQR.US)$ stock is rising more than 34% in pre-market trading today.
$IVERIC bio Inc(ISEE.US)$ shares are heading over 33% higher after announcing a written agreement from the FDA for a Special Protocol Assessment for its Phase 3 clinical trial of Zimura to treat geographic atrophy secondary to age-related macular degeneration.
$Odonate Therapeutics Inc(ODT.US)$ stock is climbing nearly 33% after revealing an increased stake from Ikarian Capital in an SEC filing.
$Axcella Health Inc(AXLA.US)$ shares were up close to 28% as of this morning.
$Marin Software Inc(MRIN.US)$ stock is gaining more than 20% as Reddit continues to favor the company.
$Ocugen Inc(OCGN.US)$ shares are increasing over 16% after revealing trial results from its coronavirus vaccine being developed with Bharat Biotech.
$Sequential Brands Group Inc(SQBG.US)$ stock is running more than 16% higher after seeing heavy trading on Friday.
$Immutep Ltd(IMMP.US)$ shares are jumping over 11% after revealing IRB approval for a Phase IIb clinical trial that will start this quarter.
$Advaxis Inc.(ADXS.US)$今天上午，在宣布与Biosight达成合并协议后，该公司股价飙升了65%以上。
$Bridgeline Digital Inc.(BLIN.US)$在透露上周通过权证交易获得了超过250万美元的现金后，该公司股价飙升了38%以上。
$BSQUARE Corp(BSQR.US)$今日盘前交易中，该股涨幅超过34%。
$IVERIC BIO Inc.(ISEE.US)$在宣布FDA为其Zimura第三阶段临床试验治疗继发于年龄相关性黄斑变性的地理萎缩进行特殊协议评估后，股价上涨了33%以上。
$Odonate治疗公司(ODT.US)$在美国证券交易委员会(SEC)提交给美国证券交易委员会(SEC)的文件中披露Ikarian Capital增持股份后，该公司股价上涨近33%。
$Axcella Health Inc.(AXLA.US)$截至今天上午，该公司股价上涨了近28%。
$Marin Software Inc.(MRIN.US)$随着Reddit继续看好该公司，该公司股价上涨了20%以上。
$Ocugen Inc(OCGN.US)$在披露了与巴拉特生物技术公司共同开发的冠状病毒疫苗的试验结果后，该公司股价上涨了16%以上。
$Sequential Brands Group Inc.(SQBG.US)$股价上涨了16%以上。在看到周五的成交量很大之后.
$Immutep Ltd(IMMP.US)$在披露IRB批准将于本季度开始的IIb期临床试验后，该公司股价跃升至11%以上。
10 Top Losers
十大输家
$Ashford Hospitality Trust Inc(AHT.US)$ stock is diving more than 26% after revealing plans for a 1-for-10 reverse stock split.
$POP CULTURE GROUP CO LTD(CPOP.US)$ stock is dropping over 15%, which continues its fall from Friday.
$Nortech Systems Inc(NSYS.US)$ shares are retreating more than 12% after running higher on Friday.
$KANZHUN LIMITED(BZ.US)$ stock is taking an over 9% beating as one of its subsidiaries is being investigated by China's watchdog group.
$Tata Motors Ltd(TTM.US)$ shares are decreasing more than 8% on warnings of chip shortages.
$Alterity Therapeutics Ltd(ATHE.US)$ stock is seeing shares lose 8% of their value in pre-market trading this morning.
$Virpax Pharmaceuticals, Inc.(VRPX.US)$ shares are declining over 7% on no apparent news.
$Staffing 360 Solutions Inc(STAF.US)$ stock is pulling back more than 7% after shares rallied on Friday.
$DouYu International Holdings Limited(DOYU.US)$ shares close out our pre-market stock movers list down over 7% this morning.
$Ashford Hotitality Trust Inc.(AHT.US)$在公布了10股换1股的反向股票拆分计划后，该公司股价暴跌逾26%。
$流行文化集团有限公司(CPOP.US)$股价下跌超过15%，这是自上周五以来的持续下跌。
$Nortech Systems Inc.(NSYS.US)$股价在上周五走高后，目前已回落逾12%。
$看准有限公司(BZ.US)$由于其一家子公司正在接受中国监管机构的调查，其股票遭受了超过9%的打击。
$塔塔汽车有限公司(TTM.US)$由于芯片短缺的警告，该公司股价下跌超过8%。
$Alterity Treeutics Ltd(ATHE.US)$在今天上午的盘前交易中，股票市值下跌了8%。
$Virpax制药公司(VRPX.US)$在没有明显消息的情况下，股价下跌了7%以上。
$人员配备360解决方案公司(STAF.US)$在上周五股价反弹后，股价回落超过7%。
$斗鱼国际控股有限公司(DOYU.US)$今天上午，股票收盘前下跌超过7%。
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
在出版之日，威廉·怀特没有(直接或间接)持有本文所述证券的任何头寸。本文表达的观点是作者的观点，以InvestorPlace.com为准出版指南.